Medical prevention and treatment of acute and chronic radiation induced enteritis - Is there any proven therapy? A short review

Zeitschrift fur Gastroenterologie

Volumn 46, Issue 5, 2008, Pages 441-448

  Zimmerer, T ^a   Bocker U ^a   Wenz, F ^a   Singer, Manfred V ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

Author keywords

Acute radiation enteritis; Chronic radiation enteritis; Prevention; Therapy

Indexed keywords

ALPHA TOCOPHEROL; ANTINEOPLASTIC AGENT; ATROPINE PLUS DIPHENOXYLATE; FLUOROURACIL; GLUTAMINE; HYDROLASE; LOPERAMIDE; MESALAZINE; OCTREOTIDE; OLSALAZINE; PALIFERMIN; PENTOXIFYLLINE; PLACEBO; PROBIOTIC AGENT; PROSTAGLANDIN; SALAZOSULFAPYRIDINE; SILICON DIOXIDE; SUCRALFATE; TRANSFORMING GROWTH FACTOR; TRANSFORMING GROWTH FACTOR BETA;

ABSENCE OF SIDE EFFECTS; ACUTE DISEASE; CHRONIC DISEASE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIARRHEA; DIET THERAPY; DRUG EFFECT; ENTERITIS; HUMAN; INCIDENCE; IRRADIATION; LACTOBACILLUS; NEOPLASM; NONHUMAN; OUTCOME ASSESSMENT; PARENTERAL NUTRITION; PROPHYLAXIS; RADIATION DOSE; RADIATION ENTEROPATHY; RADIATION INJURY; RANDOMIZED CONTROLLED TRIAL; SHORT SURVEY; TREATMENT OUTCOME; UNSPECIFIED SIDE EFFECT;

ABDOMINAL NEOPLASMS; ACUTE DISEASE; CHRONIC DISEASE; COMBINED MODALITY THERAPY; CONTROLLED CLINICAL TRIALS AS TOPIC; DIARRHEA; DOUBLE-BLIND METHOD; ENTERITIS; HUMANS; INTESTINAL MUCOSA; LOPERAMIDE; MESALAMINE; OCTREOTIDE; PARENTERAL NUTRITION, HOME; PELVIC NEOPLASMS; PENTOXIFYLLINE; PROBIOTICS; RADIATION INJURIES; SULFASALAZINE; TOCOPHEROLS;

EID: 47649108284     PISSN: 00442771     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2008-1027150     Document Type: Short Survey

References (86)

1. Yavuz MN, Yavuz AA, Aydin F et al. The efficacy of octreotide in the therapy of acute radiation-induced diarrhea: a randomized controlled study. Int J Radiat Oncol Biol Phys 2002; 54: 195-202
2. Kozelsky TF, Meyers GE, Sloan JA et al. Phase III double-blind study of glutamine versus placebo for the prevention of acute diarrhea in patients receiving pelvic radiation therapy. J Clin Oncol 2003; 21: 1669-1674
3. Yeoh EK, Horowitz M. Radiation enteritis. Surg Gynecol Obstet 1987; 165: 373-937
4. Gavazzi C, Bhoori S, Lovullo S et al. Role of home parenteral nutrition in chronic radiation enteritis. Am J Gastroenterol 2006; 101: 374-379
5. Kinsella TJ, Bloomer WD. Tolerance of the intestine to radiation therapy. Surg Gynecol Obstet 1980; 151: 273-284
6. Cotti G, Seid V, Araujo S et al. Conservative therapies for hemorrhagic radiation proctitis: a review. Rev Hosp Clin Fac Med Sao Paulo 2003; 58: 284-292
7. Martenson JA, Bollinger JW, Sloan JA et al. Sucralfate in the prevention of treatment-induced diarrhea in patients receiving pelvic radiation therapy: A North Central Cancer Treatment Group phase III double-blind placebo-controlled trial. J Clin Oncol 2000; 18: 1239-1245
8. Tanum G, Tveit KM, Karlsen KO. Chemoradiotherapy of anal carcinoma: tumour response and acute toxicity. Oncology 1993; 50: 14-17
9. Minsky BD, Kemeny N, Cohen AM et al. Preoperative high-dose leucovorin/5-fluorouracil and radiation therapy for unresectable rectal cancer. Cancer 1991; 67: 2859-2866
10. Bosset JF, Collette L, Calais G et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006; 355: 1114-1123
11. Bosset JF, Calais G, Mineur L et al. Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: preliminary results - EORTC 22921. J Clin Oncol 2005; 23: 5620-5627
12. Bosset JF, Calais G, Daban A et al. Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group. Eur J Cancer 2004; 40: 219-224
13. Valencia J, Esco R, Polo S et al. Postoperative radiochemotherapy in rectal cancer comparison of two combination schemes: alternating versus concomitant. Tumori 2004; 90: 216-224
14. Paris F, Fuks Z, Kang A et al. Endothelial apoptosis as the primary lesion initiating intestinal radiation damage in mice. Science 2001; 293: 293-297
15. Cole A. Elevated rectal leukotriene b4, thromboxane b2 and prostaglandin e2 levels in patients having pelvic radiotherapy. Abstracts of the 2nd international conference on eicosanoids and other bioactive lipids in cancer, inflammation and radiation injury 1991: 137
16. Schneidkraut MJ, Kot PA, Ramwell PW et al. Regional release of cyclooxygenase products after radiation exposure of the rat. J Appl Physiol 1986; 61: 1264-1269
17. Novak JM, Collins JT, Donowitz M et al. Effects of radiation on the human gastrointestinal tract. J Clin Gastroenterol 1979; 1: 9-39
18. Summers RW, Flatt AJ, Prihoda MJ et al. Effect of irradiation on morphology and motility of canine small intestine. Dig Dis Sci 1987; 32: 1402-1410
19. Hwang JM, Chan DC, Chang TM et al. Effects of oral arginine and glutamine on radiation-induced injury in the rat. J Surg Res 2003; 109: 149-154
20. Maj JG, Paris F, Haimovitz-Friedman A et al. Microvascular function regulates intestinal crypt response to radiation. Cancer Res 2003; 63: 4338-4341
21. Yeoh EK, Horowitz M, Russo A et al. Gastrointestinal function in chronic radiation enteritis - effects of loperamide-N-oxide. Gut 1993; 34: 476-482
22. Fernandez-Banares F, Villa S, Esteve M et al. Acute effects of abdominopelvic irradiation on the orocecal transit time: its relation to clinical symptoms, and bile salt and lactose malabsorption. Am J Gastroenterol 1991; 86: 1771-1777
23. Bagrij T, Kralovanszky J, Gyergyay F et al. Influence of uridine treatment in mice on the protection of gastrointestinal toxicity caused by 5-fluorouracil. Anticancer Res 1993; 13: 789-793
24. Pritchard DM, Watson AJ, Potten CS et al. Inhibition by uridine but not thymidine of p53-dependent intestinal apoptosis initiated by 5-fluorouracil: evidence for the involvement of RNA perturbation. Proc Natl Acad Sci USA 1997; 94: 1795-1799
25. Kakinuma S, Ohwada S. Gastric mucosal blood flow and gastric secretion following intravenous administration of 5-fluorouracil in anesthetized rats. Cancer Chemother Pharmacol 1997; 39: 357-360
26. Prakash A, Spencer CM. Balsalazide. Drugs 1998; 56: 83-89; discussion 90
27. Greenfield SM, Punchard NA, Teare JP et al. Review article: the mode of action of the aminosalicylates in inflammatory bowel disease. Aliment Pharmacol Ther 1993; 7: 369-383
28. Resbeut M, Marteau P, Cowen D et al. A randomized double blind placebo controlled multicenter study of mesalazine for the prevention of acute radiation enteritis. Radiother Oncol 1997; 44: 59-63
29. Baughan CA, Canney PA, Buchanan RB et al. A randomized trial to assess the efficacy of 5-aminosalicylic acid for the prevention of radiation enteritis. Clin Oncol (R Coll Radiol) 1993; 5: 19-24
30. Martenson Jr JA, Hyland G, Moertel CG et al. Olsalazine is contraindicated during pelvic radiation therapy: results of a double-blind, randomized clinical trial. Int J Radiat Oncol Biol Phys 1996; 35: 299-303
31. Kilic D, Egehan I, Ozenirler S et al. Double-blinded, randomized, placebo-controlled study to evaluate the effectiveness of sulphasalazine in preventing acute gastrointestinal complications due to radiotherapy. Radiother Oncol 2000; 57: 125-129
32. Rauch K, Weiland H. Therapy of radiogenic colitis with salicylazosulfapyridine (azulfidine). Strahlentherapie 1972; 143: 660-663
33. Henriksson R, Franzen L, Littbrand B. Effects of sucralfate on acute and late bowel discomfort following radiotherapy of pelvic cancer. J Clin Oncol 1992; 10: 969-975
34. Valls A, Pestchen I, Prats C et al. Multicenter double-blind clinical trial comparing sucralfate vs placebo in the prevention of diarrhea secondary to pelvic irradiation. Med Clin 1999; 113: 681-684
35. Stellamans K, Lievens Y, Lambin P et al. Does sucralfate reduce early side effects of pelvic radiation? A double-blind randomized trial. Radiother Oncol 2002; 65: 105-108
36. Klimberg VS, Salloum RM, Kasper M et al. Oral glutamine accelerates healing of the small intestine and improves outcome after whole abdominal radiation. Arch Surg 1990; 125: 1040-1045
37. Souba WW, Klimberg VS, Hautamaki RD et al. Oral glutamine reduces bacterial translocation following abdominal radiation. J Surg Res 1990; 48: 1-5
38. Jensen JC, Schaefer R, Nwokedi E et al. Prevention of chronic radiation enteropathy by dietary glutamine. Ann Surg Oncol 1994; 1: 157-163
39. Dale PS, Tamhankar CP, George D et al. Co-medication with hydrolytic enzymes in radiation therapy of uterine cervix: evidence of the reduction of acute side effects. Cancer Chemother Pharmacol 2001; 47 (Suppl): S29-S34
40. Stauder B, Streichhan. Strahlentherapeutische Nebenwirkungen bei Abdominalkrebspatienten und deren Reduktion durch hydrolytische Enzympräparate. Dtsch Zschr Onkol 1991; 23: 7-16
41. Martin T, Uhder K, Kurek R et al. Does prophylactic treatment with proteolytic enzymes reduce acute toxicity of adjuvant pelvic irradiation? Results of a double-blind randomized trial. Radiother Oncol 2002; 65: 17-22
42. Gorbach SL. Lactic acid bacteria and human health. Ann Med 1990; 22: 37-41
43. Adler U. On control of radioenteritis by the administration of living lactobacilli in gynecological carcinoma patients. Ther Umsch 1962; 19: 283-285
44. Haller J, Kraeubig H. On the modification of the radiation reaction of the intestines by a combination of living acidophilus, bifidus and coli bacteria. Strahlentherapie 1960; 113: 272-280
45. Salminen E, Elomaa I, Minkkinen J et al. Preservation of intestinal integrity during radiotherapy using live Lactobacillus acidophilus cultures. Clin Radiol 1988; 39: 435-437
46. Delia P, Sansotta G, Donato V et al. Use of probiotics for prevention of radiation-induced diarrhea. World J Gastroenterol 2007; 13: 912-915
47. Brouillard MY, Rateau JG. Adsorption potency of 2 clays, smectite and kaolin on bacterial enterotoxins. In vitro study in cell culture and in the intestine of newborn mice. Gastroenterol Clin Biol 1989; 13: 18-24
48. Hombrink J, Voss AC, Frohlich D et al. Therapy trends in the prevention of radiation-induced diarrhea after pelvic and abdominal irradiation. Results of a tricenter study. Strahlenther Onkol 1995; 171: 49-53
49. Hombrink J, Frohlich D, Glatzel M et al. Prevention of radiation-induced diarrhea by smectite. Results of a double-blind randomized, placebo-controlled multicenter study. Strahlenther Onkol 2000; 176: 173-179
50. Borek C. Antioxidants and radiation therapy. J Nutr 2004; 134: 3207S-3209S
51. Borek C, Ong A, Mason H et al. Selenium and vitamin E inhibit radiogenic and chemically induced transformation in vitro via different mechanisms. Proc Natl Acad Sci USA 1986; 83: 1490-1494
52. Dennert G, Horneber M. Selenium for alleviating the side effects of chemotherapy, radiotherapy and surgery in cancer patients. Cochrane Database Syst Rev 2006; 3: CD005037
53. Housley RM, Morris CF, Boyle W et al. Keratinocyte growth factor induces proliferation of hepatocytes and epithelial cells throughout the rat gastrointestinal tract. J Clin Invest 1994; 94: 1764-1777
54. Spielberger R, Stiff P, Bensinger W et al. Palifermin for oral mucositis after intensive therapy for hematologic cancers. N Engl J Med 2004; 351: 2590-2598
55. Farrell CL, Bready JV, Rex KL et al. Keratinocyte growth factor protects mice from chemotherapy and radiation-induced gastrointestinal injury and mortality. Cancer Res 1998; 58: 933-999
56. Hawkey CJ, Boughton-Smith NK, Whittle BJ. Modulation of human colonic arachidonic acid metabolism by sulfasalazine. Dig Dis Sci 1985; 30: 1161-1165
57. Montagna W, Wilson JW. A cytologic study of the intestinal epithelium of the mouse after total-body X-irradiation. J Natl Cancer Inst 1955; 15: 1703-1735
58. Arlow FL, Dekovich AA, Priest RJ et al. Bile acids in radiation-induced diarrhea. South Med J 1987; 80: 1259-1261
59. Urbancsek H, Kazar T, Mezes I et al. Results of a double-blind, randomized study to evaluate the efficacy and safety of Antibiophilus in patients with radiation-induced diarrhoea. Eur J Gastroenterol Hepatol 2001; 13: 391-396
60. Chapaux J, Chapaux P, Royer E. Loperamide in patients with radiotherapy-induced diarrhoea. Arzneimittelforschung 1978; 28: 864-866
61. Geginat G, Behdjati F, Green E et al. Studies using loperamide in patients with diarrhea following telecobalt irradiation of malignant abdominal tumors (author's transl). Strahlentherapie 1978; 154: 11-15
62. Viera AJ, Hoag S, Shaughnessy J. Management of irritable bowel syndrome. Am Fam Physician 2002; 66: 1867-1874
63. Zidan J, Haim N, Beny A et al. Octreotide in the treatment of severe chemotherapy-induced diarrhea. Ann Oncol 2001; 12: 227-229
64. Goumas P, Naxakis S, Christopoulou A et al. Octreotide acetate in the treatment of fluorouracil-induced diarrhea. Oncologist 1998; 3: 50-53
65. Wang J, Zheng H, Sung CC et al. The synthetic somatostatin analogue, octreotide, ameliorates acute and delayed intestinal radiation injury. Int J Radiat Oncol Biol Phys 1999; 45: 1289-1296
66. Classen J, Belka C, Paulsen F et al. Radiation-induced gastrointestinal toxicity. Pathophysiology, approaches to treatment and prophylaxis. Strahlenther Onkol 1998; 174 (Suppl 3): 82-84
67. Paulsen F, Hoffmann W, Kortmann RD et al. Acute gastrointestinal side effects of radiotherapy. What is certain in the treatment? Strahlenther Onkol 1996; 172: 53-63
68. Weiss E, Hirnle P, Arnold-Bofinger H et al. Therapeutic outcome and relation of acute and late side effects in the adjuvant radiotherapy of endometrial carcinoma stage I and II. Radiother Oncol 1999; 53: 37-44
69. Donner CS. Pathophysiology and therapy of chronic radiation-induced injury to the colon. Dig Dis 1998; 16: 253-261
70. Wang CJ, Leung SW, Chen HC et al. The correlation of acute toxicity and late rectal injury in radiotherapy for cervical carcinoma: evidence suggestive of consequential late effect (CQLE). Int J Radiat Oncol Biol Phys 1998; 40: 85-91
71. Hauer-Jensen M, Richter KK, Wang J et al. Changes in transforming growth factor beta1 gene expression and immunoreactivity levels during development of chronic radiation enteropathy. Radiat Res 1998; 150: 673-680
72. Nguyen NP, Antoine JE, Dutta S et al. Current concepts in radiation enteritis and implications for future clinical trials. Cancer 2002; 95: 1151-1163
73. Haboubi NY, Schofield PF, Rowland PL. The light and electron microscopic features of early and late phase radiation-induced proctitis. Am J Gastroenterol 1988; 83: 1140-1144
74. Regimbeau JM, Panis Y, Gouzi JL et al. Operative and long term results after surgery for chronic radiation enteritis. Am J Surg 2001; 182: 237-242
75. Delanian S, Balla-Mekias S, Lefaix JL. Striking regression of chronic radiotherapy damage in a clinical trial of combined pentoxifylline and tocopherol. J Clin Oncol 1999; 17: 3283-3290
76. Delanian S, Lefaix JL. Complete healing of severe osteoradionecrosis with treatment combining pentoxifylline, tocopherol and clodronate. Br J Radiol 2002; 75: 467-469
77. Fischer M, Wohlrab J, Marsch W. Crux medicorum ulcerated radiation-induced fibrosis - successful therapy with pentoxifylline and vitamin E. Eur J Dermatol 2001; 11: 38-40
78. Hille A, Christiansen H, Pradier O et al. Effect of pentoxifylline and tocopherol on radiation proctitis/enteritis. Strahlenther Onkol 2005; 181: 606-614
79. Shi H, Noguchi N, Niki E. Comparative study on dynamics of antioxidative action of alpha-tocopheryl hydroquinone, ubiquinol, and alpha-tocopherol against lipid peroxidation. Free Radic Biol Med 1999; 27: 334-346
80. Gothard L, Cornes P, Brooker S et al. Phase II study of vitamin E and pentoxifylline in patients with late side effects of pelvic radiotherapy. Radiother Oncol 2005; 75: 334-341
81. Jones K, Evans AW, Bristow RG et al. Treatment of radiation proctitis with hyperbaric oxygen. Radiother Oncol 2006; 78: 91-94
82. Girnius S, Cersonsky N, Gesell L et al. Treatment of refractory radiation-induced hemorrhagic proctitis with hyperbaric oxygen therapy. Am J Clin Oncol 2006; 29: 588-592
83. Huddy JE, Patel P, Johnson MW et al. Hyperbaric oxygen as a treatment for malabsorption in a radiation-damaged short bowel. Eur J Gastroenterol Hepatol 2006; 18: 685-688
84. Marshall GT, Thirlby RC, Bredfeldt JE et al. Treatment of gastrointestinal radiation injury with hyperbaric oxygen. Undersea Hyperb Med 2007; 34: 35-42
85. Scolapio JS, Ukleja A, Burnes JU et al. Outcome of patients with radiation enteritis treated with home parenteral nutrition. Am J Gastroenterol 2002; 97: 662-666
86. Gottlober P, Steinen M, Bahren W et al. Interferon-gamma in 5 patients with cutaneous radiation syndrome after radiation therapy. Int J Radiat Oncol Biol Phys 2001; 50: 159-166